View Older Stories View More Recent Stories
-
Intuitive Surgical (ISRG) Tops Q2 EPS by 26c
-
Intuitive Surgical (ISRG) call put ratio 1 call to 1.6 puts into quarter results
-
Intuitive Surgical (ISRG) call put ratio 1 call to 2 puts into quarter results
-
Intuitive demonstrates transatlantic telesurgery with da Vinci 5 system
-
Intuitive receives FDA clearance for curved vessel sealer instrument
-
Leerink Partners reiterates positive view on Intuitive Surgical (ISRG) after securing DV5 CE Mark ahead of expectations
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
UBS identifies stock winners amid structural growth tailwinds
-
Bernstein on Intuitive Surgical (ISRG): 'We'd Buy the Dip Here'
-
Deutsche Bank Downgrades Intuitive Surgical (ISRG) to Sell
-
Erste Group Upgrades Intuitive Surgical (ISRG) to Buy
-
UFP Technologies (UFPT) Initiated at Strong Sell by Off Wall Street
-
Intuitive Surgical (ISRG) Announces CEO Transition Effective July 1, 2025
-
These 2 sectors are under-owned, Barclays says and advises where to invest
-
Wolfpack Research long Intuitive Surgical (ISRG) on UFPT's dependency
-
Intuitive Surgical (ISRG) Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
-
Stifel Reiterates Buy Rating on Intuitive Surgical (ISRG)
-
Intuitive Surgical (ISRG) PT Lowered to $605 at RBC Capital
-
Intuitive Surgical (ISRG) PT Lowered to $590 at Truist Securities
-
Intuitive Surgical (ISRG) PT Lowered at Piper Sandler Despite 'Another Strong EPS Print'
-
Intuitive Surgical (ISRG) PT Lowered to $592 at Raymond James
-
Intuitive Surgical (ISRG) PT Lowered to $675, but Bernstein Reiterates Top Pick Status
-
Intuitive Surgical (ISRG) PT Lowered to $539 at Leerink Partners
-
Intuitive Surgical (ISRG) PT Lowered to $542 at BTIG
-
Intuitive Surgical (ISRG) PT Lowered to $530 at Jefferies
-
Intuitive Surgical (ISRG) PT Lowered to $470 at Evercore ISI
-
After-hours movers: Tesla, Oklo, Intuitive Surgical and more
-
Intuitive Surgical (ISRG) Tops Q1 EPS by 7c, Offers Outlook
-
Intuitive Surgical (ISRG) call put ratio 2.2 calls to 1 put into quarter results
-
Intuitive Surgical (ISRG) April 25 weekly 482.50 straddle priced into quarter results
-
Intuitive Surgical (ISRG): U.S. FDA clears first stapler designed for single-port robotic surgery
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
BofA Defending Intuitive Surgical (ISRG)
-
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold (Friday pre-market)
-
Intuitive Surgical (ISRG) PT Lowered to $605 at Truist Securities
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
BofA Comments on Trump and Mexico Tariff Delay Impact to Medical Technology Names
-
Astera Labs (ALAB) Appoints Craig Barratt to its Board
-
RBC Capital Reiterates Outperform Rating on Intuitive Surgical (ISRG) Following 'Solid 24% EPS Beat in Q4'
-
Intuitive Surgical (ISRG) PT Raised to $670 at Piper Sandler; 'Q4 Print Marks Excellent Finish To The Yr'
-
Oppenheimer Reiterates Perform Rating on Intuitive Surgical (ISRG)
-
Bernstein on Intuitive Surgical (ISRG): 'Massive Q4 EPS; Great Setup for 2025'
-
Stocks expected to have increasing option volume: ISRG TXN CSX SLM HCA AXP VZ
-
Intuitive Surgical (ISRG) PT Raised to $666 at Truist Securities
-
Intuitive Surgical (ISRG) PT Raised to $585 at Deutsche Bank
-
Intuitive Surgical (ISRG) PT Raised to $622 at BTIG
-
Intuitive Surgical (ISRG) PT Raised to $688 at Raymond James
-
Intuitive Surgical (ISRG) PT Raised to $711 at Citi
-
Intuitive Surgical (ISRG) Tops Q4 EPS by 46c
-
Intuitive Surgical (ISRG) call put ratio 2 calls to 1 put as share price up 1% into quarter results

